Antibiotic News and Research

RSS
NASH patients more likely to have increased intestinal permeability, shows study

NASH patients more likely to have increased intestinal permeability, shows study

MRSA bacteria exposed to cigarette smoke become more resistant to antimicrobial peptides

MRSA bacteria exposed to cigarette smoke become more resistant to antimicrobial peptides

Hospitals, health systems preparing to treat patients with Ebola face unexpected challenges

Hospitals, health systems preparing to treat patients with Ebola face unexpected challenges

NIH awards $2.1 million grant to counter antibiotic resistance in Gram-negative bacteria

NIH awards $2.1 million grant to counter antibiotic resistance in Gram-negative bacteria

China Pharma's revenue decreases 24% to $24.9 million in fiscal year 2014

China Pharma's revenue decreases 24% to $24.9 million in fiscal year 2014

Drug-resistant E. coli outbreak linked to contaminated endoscopes in Washington state hospital

Drug-resistant E. coli outbreak linked to contaminated endoscopes in Washington state hospital

Synthetic Biologics begins SYN-004 Phase 2a clinical trial to prevent C. difficile infection

Synthetic Biologics begins SYN-004 Phase 2a clinical trial to prevent C. difficile infection

Research: Common bacteria poised to become antibiotic-resistant superbugs

Research: Common bacteria poised to become antibiotic-resistant superbugs

Study finds C. difficile infection increases hospital readmission rates

Study finds C. difficile infection increases hospital readmission rates

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

First randomized, controlled trial of pharmacotherapy in PCD patients now in place

First randomized, controlled trial of pharmacotherapy in PCD patients now in place

Key finding may point to immediate cause of CF exacerbations

Key finding may point to immediate cause of CF exacerbations

Dipexium Pharmaceuticals reports strong financial results for year ended December 31, 2014

Dipexium Pharmaceuticals reports strong financial results for year ended December 31, 2014

A new approach to TBI therapy

A new approach to TBI therapy

Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

Researchers examine why joint infections persist despite standards of care

Researchers examine why joint infections persist despite standards of care

New article highlights the problem of antibiotic use in lab experiments

New article highlights the problem of antibiotic use in lab experiments

Two common antibiotic treatments equally effective against MRSA skin infections

Two common antibiotic treatments equally effective against MRSA skin infections

New microarray-based tool provides fast, reliable assessment of vaginal health

New microarray-based tool provides fast, reliable assessment of vaginal health

PaMZ drug regimen shows potential to improve treatment for MDR-TB

PaMZ drug regimen shows potential to improve treatment for MDR-TB

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.